Carisoprodol Tablet
Product Images NDC 72789-190

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 72789-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789190 Label (72789190)

72789190 Label (72789190)
Carisoprodol USP 350 mg tablet label from PD-Rx Pharmaceuticals, Inc., showing a 30 tablet package. The label includes dosage strength, quantity, NDC 72789-190-30, expiration date 04/2023, lot number C22C16, and a warning to keep out of reach of children. Instructions and cautionary statements are also present.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of Carisoprodol, showing its molecular composition and bonds. The diagram includes carbon, hydrogen, oxygen, and nitrogen atoms arranged to represent the chemical makeup of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.